SPONSOR
Sixth Affiliated Hospital, Sun Yat-sen University
Total Trials
14
Recruiting
14
Phases
Phase 2, Phase 3
Conditions studied: Crohn Disease (CD)Intestinal StrictureIntestinal FibrosisCancer;Cardiovascular;Adverse EventsCancerRectal CancerCrohn's DiseaseUlcerative Colitis (UC)Chemotherapy EffectColorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University is a clinical research sponsor with 14 registered studies on ClinicalTrials.gov, of which 14 are actively recruiting participants. Research covers conditions including Crohn Disease (CD), Intestinal Stricture, Intestinal Fibrosis, Cancer;Cardiovascular;Adverse Events.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Sixth Affiliated Hospital, Sun Yat-sen University
How many clinical trials has Sixth Affiliated Hospital, Sun Yat-sen University sponsored?
ClinicalMetric currently tracks 14 clinical trials sponsored by Sixth Affiliated Hospital, Sun Yat-sen University, of which 14 are actively recruiting participants. These trials cover conditions including Crohn Disease (CD), Intestinal Stricture, Intestinal Fibrosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Sixth Affiliated Hospital, Sun Yat-sen University research focus on?
Sixth Affiliated Hospital, Sun Yat-sen University clinical trials span Crohn Disease (CD), Intestinal Stricture, Intestinal Fibrosis, Cancer;Cardiovascular;Adverse Events, Cancer, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Sixth Affiliated Hospital, Sun Yat-sen University clinical trial?
To participate in a Sixth Affiliated Hospital, Sun Yat-sen University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Sixth Affiliated Hospital, Sun Yat-sen University trials with current recruitment status updated daily.
Clinical Trials by Sixth Affiliated Hospital, Sun Yat-sen University
NCT07833332
Recruiting
Endoscopic Stricturotomy Versus Balloon Dilation for Small Bowel Fibrotic Strictures in Crohn's Disease
Crohn Disease (CD)
NCT07058454
Recruiting
Multicenter Prospective Observational Study of Cardiotoxicity in Patients Receiving Targeted Cancer Therapies
Cancer;Cardiovascular;Adverse Events
NCT05523245
Recruiting
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
Rectal Cancer
NCT07545317
Recruiting
Real-World Study of IL-23 Inhibitors in Active Crohn's Disease
Crohn's Disease
NCT06095596
Recruiting
Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
Ulcerative Colitis (UC)
NCT06510010 Phase 2
Recruiting
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Chemotherapy Effect
NCT05815082 Phase 3
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
Colorectal Cancer
NCT05943444
Recruiting
Comparison of Postoperative Anal Function Between Parks and Bacon Techniques in Low Rectal Cancer
Rectal Neoplasms
NCT07176182 Phase 2
Recruiting
Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
Rectal Cancer Patients
NCT07081373
Recruiting
Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients.
Anal Fistula
NCT06241170
Recruiting
Mesenteric Surgical Margin for Crohn's Disease Endoscopic Recurrence
Endoscopic Recurrence Rate
NCT05797077 Phase 3
Recruiting
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Colorectal Cancer
NCT07808853 Phase 2
Recruiting
Node-Sparing Short-Course Radiotherapy (25 Gy/5 Fractions) Combined With Chemoimmunotherapy as Neoadjuvant Treatment for Locally Advanced Esophageal Squamous Cell Carcinoma：A Prospective Single-Arm, Phase II Study
ESCC
NCT07669220 Phase 2
Recruiting
A Multicenter, Randomized Controlled Phase II Study of Short-Course Radiotherapy Followed by Sequential PD-1 Inhibitor and FOLFOX Chemotherapy Versus Long-Course Chemoradiotherapy for High-Risk Locally Advanced pMMR/MSS Lower Rectal Adenocarcinoma (STAR Trial)
Rectal Adenocarcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology